Cited by

• ECCO2R and NIV-NAVA for stepwise early weaning in extremely severe COPD patients: a promising solution with details to be defined.

  Wang H, He H. Wang H, et al. Crit Care. 2020 Jan 28;24(1):26. doi: 10.1186/s13054-020-2735-8. Crit Care. 2020. PMID: 31992362 Free PMC article. No abstract available.
• Extracorporeal membrane oxygenation: evolving epidemiology and mortality.

  Karagiannidis C, Brodie D, Strassmann S, Stoelben E, Philipp A, Bein T, Müller T, Windisch W. Karagiannidis C, et al. Intensive Care Med. 2016 May;42(5):889-896. doi: 10.1007/s00134-016-4273-z. Epub 2016 Mar 4. Intensive Care Med. 2016. PMID: 26942446
• In vitro characterization of PrismaLung+: a novel ECCO₂R device.

  Hospach I, Goldstein J, Harenski K, Laffey JG, Pouchoulin D, Raible M, Votteler S, Storr M. Hospach I, et al. Intensive Care Med Exp. 2020 May 13;8(1):14. doi: 10.1186/s40635-020-00301-7. Intensive Care Med Exp. 2020. PMID: 32405714 Free PMC article.
• Large Animal Model of Pumpless Arteriovenous Extracorporeal CO₂ Removal Using Room Air via Subclavian Vessels.

  Witer LJ, Howard RA, Trahanas JM, Bryner BS, Alghanem F, Hoffman HR, Cornell MS, Bartlett RH, Rojas-Peña A. Witer LJ, et al. ASAIO J. 2016 Jan-Feb;62(1):110-3. doi: 10.1097/MAT.0000000000000291. ASAIO J. 2016. PMID: 26461241 Free PMC article.
• Control of respiratory drive by extracorporeal CO₂ removal in acute exacerbation of COPD breathing on non-invasive NAVA.

  Karagiannidis C, Strassmann S, Schwarz S, Merten M, Fan E, Beck J, Sinderby C, Windisch W. Karagiannidis C, et al. Crit Care. 2019 Apr 23;23(1):135. doi: 10.1186/s13054-019-2404-y. Crit Care. 2019. PMID: 31014366 Free PMC article.